Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Methotrexate Injection for Cesarean Scar and Cervical Ectopic Pregnancies
jRCTs031250822Recruiting
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methotrexate in Ectopic pregnancy (EP). Primary endpoint: Frequency of severe uterine bleeding. Started Apr 2026; status: recruiting.
02
Drugs
methotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on jRCTs031250822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250822.